Literature DB >> 19120316

Insulitis in human type 1 diabetes.

Toshiaki Hanafusa1, Akihisa Imagawa.   

Abstract

Pancreatic tissues were analyzed immunohistologically in patients with autoimmune and fulminant type 1 diabetes (T1D) and control subjects. Both beta and alpha cells were decreased in fulminant T1D, but only beta cells were significantly decreased in autoimmune T1D. Insulitis was seen in both subtypes of T1D, but it remained longer in autoimmune than in fulminant T1D. Lymphocytic infiltration to the exocrine pancreatic tissue was observed only in fulminant T1D, whereas immunologically abnormal findings, such as increased expression of MHC class I molecule and Fas antigen in islet cells and Fas-ligand expression in infiltrating lymphocytes, were detected only in autoimmune T1D. From these findings, together with clinical features, it could be concluded that in autoimmune T1D, beta cells are assumed to be destroyed through a long-standing autoimmune process, whereas in fulminant T1D, beta cells seem to be destroyed very rapidly, probably by a destructive process triggered by viral infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120316     DOI: 10.1196/annals.1447.052

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program.

Authors:  Joris van Arensbergen; Javier García-Hurtado; Ignasi Moran; Miguel Angel Maestro; Xiaobo Xu; Mark Van de Casteele; Anouchka L Skoudy; Matteo Palassini; Harry Heimberg; Jorge Ferrer
Journal:  Genome Res       Date:  2010-04-15       Impact factor: 9.043

2.  Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide.

Authors:  Y J Park; S Lee; T J Kieffer; G L Warnock; N Safikhan; M Speck; Z Hao; M Woo; L Marzban
Journal:  Diabetologia       Date:  2012-02-01       Impact factor: 10.122

Review 3.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

Review 4.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

5.  Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Authors:  Hidekatsu Yanai; Sumie Moriyama
Journal:  World J Diabetes       Date:  2011-05-15

6.  Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes.

Authors:  Mi-Young Song; Gil-Saeng Jeong; Kang-Beom Kwon; Sun-O Ka; Hyun-Young Jang; Jin-Woo Park; Youn-Chul Kim; Byung-Hyun Park
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

Review 7.  Strategies for clinical trials in type 1 diabetes.

Authors:  Mario R Ehlers
Journal:  J Autoimmun       Date:  2016-04-05       Impact factor: 7.094

Review 8.  Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines.

Authors:  Yaíma L Lightfoot; Jing Chen; Clayton E Mathews
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

9.  Impaired glucagon secretion in patients with fulminant type 1 diabetes mellitus.

Authors:  Hisako Komada; Yushi Hirota; Kazuhiko Sakaguchi; Yoko Okuno; Wataru Ogawa; Susumu Seino
Journal:  Endocrine       Date:  2018-09-10       Impact factor: 3.633

Review 10.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.